Pharmacogenomics and the potential capabilities of sequencing technology are used to create future medicine which might be used by patients without much assistance. A healthy Malay male was asked of his parent’s medical history. Based from the history, the study was able to develop a working system and algorithm which shows the flow of possible variations in pharmacogenomics analysis (Salleh et al, 2013). The analysis showed that there are 607 variations found within the pathway of drugs. This only means that there are several potentials which can be used in medical practice. As a result, the study is successful in finding genomes which are potential candidate for sequencing with the purpose of creating personalized medicine using the findings on the different variations found in the study (Salleh et al, 2013).
Research studies such as this should be encouraged among experts so that there will be better medications for the next generation. Furthermore, the development of personalized drugs would prevent spread of different strains of disease since the drug is intended for a single person with a unique pattern of drug metabolism (Pirmohamed, 2001). In addition, pharmacogenetics and pharmacogenomics have high potentials in developing medicines which will adapt to the evolutionary changes of mankind in the future (Lindpaintner, 2002). If this is the case, then the information about these scientific developments should be disseminated to the people so that they will be knowledgeable about the possible medicines of the future. Also, more people will become willing of participating in the study in order to find new discoveries and develop drugs which are not harmful and will not become a source of disease in the future. The systematic pharmacogenomics analysis of a Malay proved that the process is harmless, and the success of the study only means that there is really potential for new discoveries, as well as new developments in the field of medicine and medical technology.
References
Lindpaintner, K. (2002). Pharmacogenetics and the future of medical practice. British Journal of Clinical Pharmacology, 54(2), 221-230.
Pirmohamed, M. (2001). Pharmacogenetics and pharmacogenomics. British Journal of Clinical Pharmacology, 52(4), 345-347.
Salleh, M., Teh, L., Lee, L., Ismet, R., Patowary, A., Joshi, K., . . . Sivasubbu, S. (2013). Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine. Public Library of Science, 8(8).
